Shah, N. D., & Limetkai, B. N. (2017). The use of Medium-Chain Triglycerides in Gastrointestinal Disorders. Practical Gastroenterology, 20-28.
Smeets, R. L., Rao, R. V., Emst-de Vries van, S. E., De Pont, J. J., Miller, L. J., & Willems, P. H. (1998). Reduced cholecystokinin receptor phosphorylation and restored signalling in protein kinase C down-regulated rat pancreatic acinar cells. Pflugers Arch., 422-428.
Limetkai, B. N., & Zucker, S. D. (2008). Hyperammonemic encephalopathy caused by carnitine deficiency. J. Gen. Inter. Med., 210-213.
Symersky, T., Vu, M. K., & Frolich, M. (2002). The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin. Physiol. Funct. Imaging, 307-311.
Sankararaman, S., & Sferra, T. (2018). Are We Going Nuts on Coconut Oil? Current Nutrition Reports, 107-115.
Ingle, D. L., Driedger, A., Traul, K. A., & Nakhasi, D. K. (1999). Dietary energy value of medium-chain triglycerides. Journal of Food Science, 960-963.
Shea, J. C., Bishop, M. D., & Parker, E. M. (2003). An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis. Pancreatology, 36-40.
Jeppesen, P. B., & Mortensen, P. B. (1998). The influence of a preserved colon on the absortion of medium chain fat in patients with small bowel resection. Gut, 478-483.
Abu Hilal, M., Layfield, D. M., & Di Fabio, F. (2013). Postoperative chyle leak after major pancreatic resections in patients who receive enteral feed; risk factors and management options. World J. Surg., 2918-2926.
McCray, S., & Parrish, C. R. (2011). Nutritional management of Chyle leaks. Practical gastroenterology, 12-32.
Smoke, A., & DeLegge, M. H. (2008). Chyle Leaks: Consensus on management? Nutr. Clin. Prac., 529-532.
Das, A., & Shah, P. S. (2010). Octreotide for the treatment of chylothorax in neonates. Cochrane database Syst. Rev., CD006388.
Jensen, G. L., Mascioli, E. A., & Meyer, L. P. (1989). Dietary modification of chyle composition in chylothorax. Gastroenterology.
Sahoo, T., Mangla, M. K., Sethi, A., & Thukral, A. (2018). Successful treatment of congenital chylothorax with skimmed milk and long course octreotide. BMJ Case Rep., 226347.
Neumann, L., Springer, T., Nieschke, K., Kostelka, M., & Dahnert, I. (2020). ChyloBEST: Chylothorax in infants and nutrition with low-fat breats milk. Pediatr. Cardiol., 108-113.
Hermon, M., Tenner, E., Gudrun, B., Strohmaier, W., Schlager, G., & Golej, J. (2019). Chylothorax and Chylous-like diseases in children: clinical management. Front Pediatr., 258.
Lieber, C. S., Lefevre, A., & Spritz, N. (1967). Difference in hepatic metabolism of long- and medium-chain fatty acids; the role of fatty acid chain length in the production of the alcohol fatty liver. The journal of clinical investigation, 451-460.
Nanji, A. A., Yang, E. K., & Fogt, F. (1996). Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol. Exp. Ther., 1694-1700.
Ronis, M. J., Baumgardner, J. N., Sharma, N., Vantrease, J., Ferguson, M., Tong, Y., . . . Badger, T. M. (2013). Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. Exp. Biol. Med., 151-162.
Morgan, M. H., Bolton, C. H., Morris, J. S., & Read, A. E. (1974). Medium chain triglycerides and hepatic encephalopathy. Gut, 180-184.
Chamma, C. M., Bargut, T. C., Mandarim-de-Lacerda, C. A., & Aguila, M. B. (2017). A rich medium-chain triacylglycerol diet benefits adiposity but has adverse effects on the markers of hepatic lipogenesis and beta-oxidation. Food Funct., 778-787.
Williams, T. J., & Cervenka, M. C. (2017). The role for ketogenic diets in epilepsy and status epilepticus in adults. Clin. Neurophysiol. Pract., 154-160.
van Berkel, A. A., IJff, D. M., & Verkuyl, J. M. (2018). Cognitive benefits of the ketogenic diet in patients with epilepsy, a systematic overview. Epilepsy Behav., 69-77.
Sadeghifar, F., & Baute Penry, V. (2019). Mechanisms of uses of dietary therapy as a treatment for epilepsy: a review. Global advances in health and medicine, 1-4.
Liu, Y. C., & Wang, H. S. (2013). Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed. J. , 9-15.
Augustin, K., Khabbush, A., Williams, S., Eaton, S., Orford, M., Cross, H., . . . Williams, R. S. (2018). Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol., 84-93.
Cameros-Luna, L., & Massieu, L. (2020). Therapeutic strategies for ketosis induction and their potential efficacy for the treatment of acute brain injury and neurodegenerative diseases. Neurochem. Int., 104614.
Lilamand, M., Porte, B., Cognat, E., Hugon, J., Mouton-liger, F., & Paquet, C. (2020). Are ketogenic diets promising for Alzheimer's disease? a translational review. Alzheimer's Research & Therapy, 10.1186/s13195.
Abuduxikuer, K., Chen, R., Wang, Z. L., & Wang, J. S. (2019). Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin defiency (NICCD) and clinical implications. BMC Pediatr., 10.1186/s12887-018-1383-5.
Francavilla, R., Miniello, V. L., Brunetti, L., Lionette, M. E., & Armenio, L. (2003). Hepatitis and cholestasis in infancy: clinical and nutritional aspects. Acta Paediatr. Suppl., 10.1111/j.1651-2227.2003.tb00656.x.
Hayasaka, K., & Numakura, C. (2018). Adult-onset type II citrullinemia; Current insights and therapy. Appl. Clin. Genet., 163-170.
Biewer, E. S., Zurn, C., Arnold, R., Glockler, M., Schulte-Monting, J., Schlensak, C., & Dittrich, S. (2010). Chylothorax after surgery on congenital heart disease in newborns and infants - risk factors and efficacy of MCT diet. J. Cardiothorac. Surg., 10.1186/1749-8090-5-127.
Korff, S. G., Ross, J., Morella, K., & Taylor, S. N. (2019). Investigation of a common clinical approach to poor growth in preterm infants. Am. J. Perinatol., 10.1055/s-0039-1694724.
Arsenault, A. B., Gunsalus, K. T., Laforce-Nesbitt, S. S., Przytac, L., DeAngelis, E. J., Hurley, M. E., . . . Bliss, J. M. (2019). Dietary supplementation with medium-chain triglycerides reduces candida gastrointestinal colonization in preterm infants. Pediatr. Infect. Dis. J., 164-168.
Shah, N. D., & Limetkai, B. N. (2017). The use of Medium-Chain Triglycerides in Gastrointestinal Disorders. Practical Gastroenterology, 20-28.
Smeets, R. L., Rao, R. V., Emst-de Vries van, S. E., De Pont, J. J., Miller, L. J., & Willems, P. H. (1998). Reduced cholecystokinin receptor phosphorylation and restored signalling in protein kinase C down-regulated rat pancreatic acinar cells. Pflugers Arch., 422-428.
Limetkai, B. N., & Zucker, S. D. (2008). Hyperammonemic encephalopathy caused by carnitine deficiency. J. Gen. Inter. Med., 210-213.
Symersky, T., Vu, M. K., & Frolich, M. (2002). The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin. Physiol. Funct. Imaging, 307-311.
Sankararaman, S., & Sferra, T. (2018). Are We Going Nuts on Coconut Oil? Current Nutrition Reports, 107-115.
Ingle, D. L., Driedger, A., Traul, K. A., & Nakhasi, D. K. (1999). Dietary energy value of medium-chain triglycerides. Journal of Food Science, 960-963.
Shea, J. C., Bishop, M. D., & Parker, E. M. (2003). An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis. Pancreatology, 36-40.
Jeppesen, P. B., & Mortensen, P. B. (1998). The influence of a preserved colon on the absortion of medium chain fat in patients with small bowel resection. Gut, 478-483.
Abu Hilal, M., Layfield, D. M., & Di Fabio, F. (2013). Postoperative chyle leak after major pancreatic resections in patients who receive enteral feed; risk factors and management options. World J. Surg., 2918-2926.
McCray, S., & Parrish, C. R. (2011). Nutritional management of Chyle leaks. Practical gastroenterology, 12-32.
Smoke, A., & DeLegge, M. H. (2008). Chyle Leaks: Consensus on management? Nutr. Clin. Prac., 529-532.
Das, A., & Shah, P. S. (2010). Octreotide for the treatment of chylothorax in neonates. Cochrane database Syst. Rev., CD006388.
Jensen, G. L., Mascioli, E. A., & Meyer, L. P. (1989). Dietary modification of chyle composition in chylothorax. Gastroenterology.
Sahoo, T., Mangla, M. K., Sethi, A., & Thukral, A. (2018). Successful treatment of congenital chylothorax with skimmed milk and long course octreotide. BMJ Case Rep., 226347.
Neumann, L., Springer, T., Nieschke, K., Kostelka, M., & Dahnert, I. (2020). ChyloBEST: Chylothorax in infants and nutrition with low-fat breats milk. Pediatr. Cardiol., 108-113.
Hermon, M., Tenner, E., Gudrun, B., Strohmaier, W., Schlager, G., & Golej, J. (2019). Chylothorax and Chylous-like diseases in children: clinical management. Front Pediatr., 258.
Lieber, C. S., Lefevre, A., & Spritz, N. (1967). Difference in hepatic metabolism of long- and medium-chain fatty acids; the role of fatty acid chain length in the production of the alcohol fatty liver. The journal of clinical investigation, 451-460.
Nanji, A. A., Yang, E. K., & Fogt, F. (1996). Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol. Exp. Ther., 1694-1700.
Ronis, M. J., Baumgardner, J. N., Sharma, N., Vantrease, J., Ferguson, M., Tong, Y., . . . Badger, T. M. (2013). Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. Exp. Biol. Med., 151-162.
Morgan, M. H., Bolton, C. H., Morris, J. S., & Read, A. E. (1974). Medium chain triglycerides and hepatic encephalopathy. Gut, 180-184.
Chamma, C. M., Bargut, T. C., Mandarim-de-Lacerda, C. A., & Aguila, M. B. (2017). A rich medium-chain triacylglycerol diet benefits adiposity but has adverse effects on the markers of hepatic lipogenesis and beta-oxidation. Food Funct., 778-787.
Williams, T. J., & Cervenka, M. C. (2017). The role for ketogenic diets in epilepsy and status epilepticus in adults. Clin. Neurophysiol. Pract., 154-160.
van Berkel, A. A., IJff, D. M., & Verkuyl, J. M. (2018). Cognitive benefits of the ketogenic diet in patients with epilepsy, a systematic overview. Epilepsy Behav., 69-77.
Sadeghifar, F., & Baute Penry, V. (2019). Mechanisms of uses of dietary therapy as a treatment for epilepsy: a review. Global advances in health and medicine, 1-4.
Liu, Y. C., & Wang, H. S. (2013). Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed. J. , 9-15.
Augustin, K., Khabbush, A., Williams, S., Eaton, S., Orford, M., Cross, H., . . . Williams, R. S. (2018). Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol., 84-93.
Cameros-Luna, L., & Massieu, L. (2020). Therapeutic strategies for ketosis induction and their potential efficacy for the treatment of acute brain injury and neurodegenerative diseases. Neurochem. Int., 104614.
Lilamand, M., Porte, B., Cognat, E., Hugon, J., Mouton-liger, F., & Paquet, C. (2020). Are ketogenic diets promising for Alzheimer's disease? a translational review. Alzheimer's Research & Therapy, 10.1186/s13195.
Abuduxikuer, K., Chen, R., Wang, Z. L., & Wang, J. S. (2019). Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin defiency (NICCD) and clinical implications. BMC Pediatr., 10.1186/s12887-018-1383-5.
Francavilla, R., Miniello, V. L., Brunetti, L., Lionette, M. E., & Armenio, L. (2003). Hepatitis and cholestasis in infancy: clinical and nutritional aspects. Acta Paediatr. Suppl., 10.1111/j.1651-2227.2003.tb00656.x.
Hayasaka, K., & Numakura, C. (2018). Adult-onset type II citrullinemia; Current insights and therapy. Appl. Clin. Genet., 163-170.
Biewer, E. S., Zurn, C., Arnold, R., Glockler, M., Schulte-Monting, J., Schlensak, C., & Dittrich, S. (2010). Chylothorax after surgery on congenital heart disease in newborns and infants - risk factors and efficacy of MCT diet. J. Cardiothorac. Surg., 10.1186/1749-8090-5-127.
Korff, S. G., Ross, J., Morella, K., & Taylor, S. N. (2019). Investigation of a common clinical approach to poor growth in preterm infants. Am. J. Perinatol., 10.1055/s-0039-1694724.
Arsenault, A. B., Gunsalus, K. T., Laforce-Nesbitt, S. S., Przytac, L., DeAngelis, E. J., Hurley, M. E., . . . Bliss, J. M. (2019). Dietary supplementation with medium-chain triglycerides reduces candida gastrointestinal colonization in preterm infants. Pediatr. Infect. Dis. J., 164-168.
Bang, U. C., Semb, S., Nordgaard-Lassen, I., & Jensen, J. E. (2009). A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr. Res., 671-675.
Tessier, A., & Chevalier, S. (2018). An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 10.3390/nu10081099.
Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that vitamin D supplementation could reduce the risk of influenza and COVID-19 infections and deaths. Nutrients, 10.3390/nu12040988.
Cashman, K., Dowling, K., Skrabakova, Z., Gonzales-Gross, M., Valtuena, J., & Henauw de, S. (2016). Vitamin D deficiency in Europe: pandemic? Am. J. Clin. Nutr., 1033-1044.
Martucci, G., Tuzzolino, F., Arcadipane, A., Pieber, T., Schnedl, C., & Purkart, T. (2017). The effect of high-dose cholecalciferol on bioavailable vitamin D levels in critically ill patients: a post hoc analysis of the VITdAL-ICU trial. Intensiv. Care Med., 1732-1734.
Haq, A., Svobodova, J., Imran, S., Stanford, C., & Razzaque, M. (2016). Vitamin D deficiency: a single centre analysis of patients from 136 countries. J. Steroid Biochem. Mol. Biol., 209-213.
Lu, Z., Chen, T., Zhang, A., Persons, K., Kohn, N., Berkowitz, R., . . . Holick, M. (2007). An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J. Steroid Biochem. Mol. Biol., 642-644.
GOV.UK. (2020, November 28). Retrieved from Preparing for winter: vitamin D: https://www.gov.uk/government/publications/vitamin-d-supplementation-during-winter-phe-and-nice statement/statement-from-phe-and-nice-on-vitamin-d-supplementation-during-winter
National Institutes of Health. (2021, January 29). Retrieved from Vitamin D: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Amrein, K., Scherkl, M., Hoffmann, M., Neuwersch-Sommeregger, S., Kostenberger, M., Tmava Berisha, A., . . . Malle, O. (2020). Vitamin D deficiency 2.0: an update on the current status worldwide. Eur. J. Clin. Nutr., doi.org/10.1038/s41430-020-0558-y.
Holick, M., Binkley, N., Bischoff-Ferrari, H., Gordon, C., Hanley, D., & Heany, R. (2011). Evaulation, treatment and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab., 1911-1930.
Vieth, R. (2004). Vitamin D is not a hormone, and not a synonym for 1,25-dihydroxy-vitamin D, its analogs of deltanoids. J. Steroid Biochem. Mol. Biol., 89-90.
Vieth, R. (2020). Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol. . Eur. J. Clin. Nutr., doi.org/10.1038/s41430-020-0697-1.
Vieth, R. (2007). Vitamin D toxicity, policy, and science. J. Bone Miner. Res, V64-V68.
EFSA Panel on dietitic products, E. (2012). Scientific opinion on the tolerable upper intake levels of vitamin D. EFSA J., 2813.
Hathcock, J., Shao, A., Vieth, R., & Heaney, R. (2007). Risk assessment for vitamin D. Am. J. Clin. Nutr., 6-18.
Martineau, A., Jollife, D., Hooper, R., Greenberg, L., Aloia, J., & Bergman, P. (2017). Vitamin D supplementation to prevent acute respiratory tract infections; systematic review and meta-analysis of individual participant data. B. M. J., i6583.
Bjelakovic, G., Gluud, L., Nikolova, D., Whitfield, K., Wetterslev, J., & Simonetti, R. (2014). Vitamin D supplementation for prevention of mortality in adults. Cochrane Datab. Syst. Rev., doi.org/10.1002/14651858.CD007470.pub3.
Gaksch, M., Jorde, R., Grimnes, G., Joakimsen, R., Schirmer, H., & Wilsgaard, T. (217). Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a Eurpoean consortium. PLOS ONE, e0170791.
Vos, R., Ruttens, D., Verleden, S., Vandermeulen, E., Bellon, H., & Van Herck, A. (2017). High-dose vitamin D after lung transplantation: a randomized trial. J. Heart Lung Transplant, 897-905.
Ma, H., Zhou, T., Heianza, Y., & Qi, L. (2021). Habitual use fo vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infcetion: a prospective study in UK biobank. Am. J. Clin. Nutr., doi:101093/ajcn/nqaa381.
Demir, M., Demir, F., & Aygun, H. (2021). Vitamin D deficiency is associated with COVID-19 positivity and the severity of the diseases. J. Med. Virol., doi: 10.1002/jm.26832.
Rostami, M., Tehrani, F., Simbar, M., Bidhendi Yarandi, R., Minooe, S., & Hollis, B. (2018). Effectiveness of prenatal vitamin D deficiency screening and treatment program: a stratified randomized field trial. J. Clin. Endocrinol. Metab., 2936-2948.
Kusunose, K., Okushi, Y., Okayama, Y., Zheng, R., Abe, M., Nakai, M., . . . Tobiume, T. (2021). Association between vitamin D and heart failure mortality in 10,974 hospitalized individuals. Nutrients, doi:10.3390/nu13020335.
Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.
Wagner, I., & Musso, H. (1983). New Naturally occurring amino acids. Angewandte Chemie International edition in English, 816-828.
Dancojocari. (n.d.). own work. wikimedia.
Young, V. R. (1994). Adult amino acid requirements: the case for a major revision in current recommendations. J. Nutr., 1517s-1523s.
Dietzen, D. J. (2018). Amino acids, peptides, and proteins Textbook of clinical chemistry and molecular diagnostics. Elsevier.
Carbone, J. W., & Pasiakos, S. M. (2019). Dietary protein and muscle mass: translating science to application. Nutrients, 1136.
Carbone, J. W., McClung, J. P., & Pasiakos, S. M. (2019). Recent advances in the characterization of skeletal muscle and whole-body protein responses to dietary protein and exercise during negative energy balance. Adv. Nutri., 70-79.
Loenneke, J. P., Loprinzi, P. D., Murphy, C. H., & Phillips, S. M. (2016). Per meal dose and frequency of protein consumption is associated with lean mass and muscle performance. Clin. Nutr., 1506-1511.
Berner, L. A., Becker, G., Wise, M., & Doi, J. (2013). Characterization of dietary protein among older adults in the United States: Amount, animal sources, and meal patterns. J. Acad. Nutr. Diet., 809-815.
Schaafsma, G. (2012). Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr., S333-S336.
Lonnie, M., Hooker, E., Brunstrom, J. M., Corfe, B. M., Green, M. A., Watson, A. W., . . . Johnstone, A. M. (2018). Protein for life: Review of optimal protein inake, sustainable dietary sources and the effect on appetite in ageing adults. Nutrients, 360.
Kiesswetter, E., Sieber, C. C., & Volkert, D. (2020). Protein intake in older people. Gerontologie+Geriatrie, 10.1007/s00391-020-01723-4.
MNI. (2018). Medical Nutrition Dossier. Retrieved from https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/
Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019). Sarcopenia. Joint Bone Spine, 309-314.
Bonnefoy, B., Gilbert, T., Bruyere, O., Paillaud, E., Raynaud-Simon, A., Guerin, O., . . . Berrut, G. (2019). Protein supplementation to prevent loss in muscle mass and strength in frail older patients: a review. Geriatr. Psychol. Neuropsychiatr. Vieil., 137-143.
Wojzischke, J., Wijngaarden van, J., Berg van den, C., Cetinyurek-yavuz, A., Diekmann, R., Luiking, Y., & Bauer, J. (2020). Nutritional status and functionality in geriatric rehabilitation patients: a systematic review and meta-analysis. Eur. Geriatr. Med., 195-207.
Tieland, M., Borgonjen-van den Berg, K. J., Loon van, L. J., & Groot de, L. C. (2012). Dietary protein intake in community-dwelling, frail, and institutionalized elderly people: scope for improvement. Eur. J. Nutr., 173-179.
Bossola, M., Pacelli, F., Rosa, F., Tortorelli, A., & Bastista, D. G. (2011). Review: does nutrition support stimulate tumor growth in humans? Nutr. Clin. Pract., 174-180.
Prado, C. M., Purcell, S. A., & Laviano, A. (2020). Nutrition interventions to treat low muscle mass in cancer. Journal of cachexia, sarcopenia and muscle, 366-380.
Arends, J., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E., Erickson, N., . . . McMillan, D. C. (2017). ESPEN expert group recommendations for action against cancer-related malnutrition. Clinical Nutrition, 1187-1196.
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., & McCargar, L. J. (2013). Cancer cachexia in the age of obesity; skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol., 1539-1547.
Bauer, J., Morley, J. E., Schols, A. M., Ferrucci, L., Cruz-Jentoft, A. J., & Dent, E. (2019). Sarcopenia: a time for action. An SCWD Position Paper. J. Cachexia Sarcopenia Muscle, 0.
Bozzetti, F. (2013). Nutritional support of the oncology patient. Crit. Rev. Oncol. Hematol., 172-200.
Collins, P. F., Yang, I. A., Chang, Y., & Vaughan, A. (2019). Nutritional support in chronic obstructive pumonary disease (COPD): an evidence update. J. Thorac Dis., S2230-S2237.
Collins, P. F., Elia, M., & Stratton, R. J. (2013). Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology, 616-629.
Habaybeh, D., Bordinhon de Moraes, M., Slee, A., & Avgerinou, C. (2020). Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or chachexia: a systematic review and meta-analysis. Haert Failure Reviews, 10.1007/s10741-020-09937-9.
Nichols, S., McGregor, G., Al-Mohammad, A., Ali, A. N., Tew, G., & O'Doherty, A. F. (2019). The effect of protein and essential amino acid supplementation on muscle strenght and performance in patients with chronic heart failure: a systematic review. Eur. J. of Nutr., 10.1007/s00394-019-02108-z.
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schutz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 485-521.
Singer, P., Reintam Blaser, A., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., . . . Montejo, J. C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical nutrition, 48-79.
Weijs, P. J., Stapel, S. N., Groot de, S. D., Driessen, R. H., Jong, E., & Girbes, A. R. (2012). Optimal protein and energy mortality in mechanically ventilated critically ill patients: a prospective cohort study. J. Parenter. Enteral Nutr., 60e8.
Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.
Wagner, I., & Musso, H. (1983). New Naturally occurring amino acids. Angewandte Chemie International edition in English, 816-828.
Young, V. R. (1994). Adult amino acid requirements: the case for a major revision in current recommendations. J. Nutr., 1517s-1523s.
Dietzen, D. J. (2018). Amino acids, peptides, and proteins Textbook of clinical chemistry and molecular diagnostics. Elsevier.
Durani, S. (2008). Protein design with L- and D-alpha-amino acid structures as the alphabet. Acc. Chem. Res., 1301-1308.
Amino acids. (2020). Retrieved from MedlinePlus: https://medlineplus.gov/ency/article/002222.htm
Kim, H. (2011). Glutamine as an immononutrient. Yonsei Med. J., 892-897.
Lenders, C. M., Liu, S., Wilmore, D. W., Sampson, L., Dougherty, L. W., Spiegelman, D., & Willett, W. C. (2009). Evaluation of a novel food composition database that includes glutamine and other amino acids derived from gene squencing data. Eur. J. Clin. Nutr., 1433-1439.
Gleeson, M. (2008). Dosing and efficacy of glutamine supplementation in human exercise and sport training. The Journal of Nutrition, 2045S-2049S.
Demling, R. H. (2009). Nutrition, anabolism, and the wound healing process: an overview. Eplasty, e9.
Mittendorfer, B., Gore, D. C., Herndon, D. N., & Wolfe, R. R. (1999). Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration. J. Parenter. Enteral Nutr., 243-250.
Calder, P. C., & Yaqoob, P. (1999). Glutamine and the immune system. Amino acids, 227-241.
Hulst van der, R. R., Meyenfeldt von, M. F., & Soeters, P. B. (1996). Glutamine: an essential amino acid for the gut. Nutrition, S78-S81.
Singer, P., Reintam Blaser, A., Berger, M. M., Alhazzani, W., Calder, P., Casaer, M. P., . . . Pichard, C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical Nutrition, 48-79.
Rodas, P. C., Rooyackers, O., Hebert, C., Norberg, A., & Wernerman, J. (2012). Glutamine and glutathione at ICU admission in relation to outcome. Clin. Sci., 591-597.
Zanten van, A. R., Dhaliwal, R., Garrel, D., & Heyland, D. K. (2015). Enteral glutamine supplementation in critically ill patients; a systematic review and meta-analysis. Crit. Care, 19:294.
Rousseau, A., Losser, M. R., Ichai, C., & Berger, M. M. (2013). ESPEN endorsed recommendations: nutritional therapy in major burns. Clin. Nutr., 497-502.
Houdijk, A. P., Rijnsburger, E. R., Wesdorp, R. I., Weiss, J. K., McCamish, M. A., & Teerlink, T. (1998). Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet, 772-776.
Wischmeyer, P. E. (2019). The glutamine debate in surgery and critical care. Curr. Opin. Crit. Care, 322-328.
Chen, M. J., Wu, I. C., Chen, Y. J., Wang, T. E., Chang, Y. F., Yang, C. L., . . . Wu, M. S. (2018). Nutrition therapy in esophageal cancer-consensus statement of the gastroenterological society of Taiwan. Dis. Esophagus., 10.1093/dote/doy016.
Jolfaie, N. R., Mirzaie, S., Ghiasvand, R., Askari, G., & Miraghajani, M. (2015). The effect of glutamine intake on complications of colorectal and clon cancer treatment: a systematic review. J. Res. Med. Sci., 910-918.
Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.
Schaafsma, G. (2012). Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr., S333-S336.
Lonnie, M., Hooker, E., Brunstrom, J. M., Corfe, B. M., Green, M. A., Watson, A. W., . . . Johnstone, A. M. (2018). Protein for life: Review of optimal protein inake, sustainable dietary sources and the effect on appetite in ageing adults. Nutrients, 360.
MNI. (2018). Medical Nutrition Dossier. Retrieved from https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/
Kiesswetter, E., Sieber, C. C., & Volkert, D. (2020). Protein intake in older people. Gerontologie+Geriatrie, 10.1007/s00391-020-01723-4.
Tessier, A., & Chevalier, S. (2018). An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 10.3390/nu10081099.
Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019). Sarcopenia. Joint Bone Spine, 309-314.
Bonnefoy, B., Gilbert, T., Bruyere, O., Paillaud, E., Raynaud-Simon, A., Guerin, O., . . . Berrut, G. (2019). Protein supplementation to prevent loss in muscle mass and strength in frail older patients: a review. Geriatr. Psychol. Neuropsychiatr. Vieil., 137-143.
Wojzischke, J., Wijngaarden van, J., Berg van den, C., Cetinyurek-yavuz, A., Diekmann, R., Luiking, Y., & Bauer, J. (2020). Nutritional status and functionality in geriatric rehabilitation patients: a systematic review and meta-analysis. Eur. Geriatr. Med., 195-207.
Tieland, M., Borgonjen-van den Berg, K. J., Loon van, L. J., & Groot de, L. C. (2012). Dietary protein intake in community-dwelling, frail, and institutionalized elderly people: scope for improvement. Eur. J. Nutr., 173-179.
Prado, C. M., Purcell, S. A., & Laviano, A. (2020). Nutrition interventions to treat low muscle mass in cancer. Journal of cachexia, sarcopenia and muscle, 366-380.
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., & McCargar, L. J. (2013). Cancer cachexia in the age of obesity; skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol., 1539-1547.
Arends, J., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E., Erickson, N., . . . McMillan, D. C. (2017). ESPEN expert group recommendations for action against cancer-related malnutrition. Clinical Nutrition, 1187-1196.
Bauer, J., Morley, J. E., Schols, A. M., Ferrucci, L., Cruz-Jentoft, A. J., & Dent, E. (2019). Sarcopenia: a time for action. An SCWD Position Paper. J. Cachexia Sarcopenia Muscle, 0.
Bozzetti, F. (2013). Nutritional support of the oncology patient. Crit. Rev. Oncol. Hematol., 172-200.
Bossola, M., Pacelli, F., Rosa, F., Tortorelli, A., & Bastista, D. G. (2011). Review: does nutrition support stimulate tumor growth in humans? Nutr. Clin. Pract., 174-180.
Collins, P. F., Yang, I. A., Chang, Y., & Vaughan, A. (2019). Nutritional support in chronic obstructive pumonary disease (COPD): an evidence update. J. Thorac Dis., S2230-S2237.
Collins, P. F., Elia, M., & Stratton, R. J. (2013). Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology, 616-629.
Habaybeh, D., Bordinhon de Moraes, M., Slee, A., & Avgerinou, C. (2020). Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or chachexia: a systematic review and meta-analysis. Heart Failure Reviews, 10.1007/s10741-020-09937-9.
Nichols, S., McGregor, G., Al-Mohammad, A., Ali, A. N., Tew, G., & O'Doherty, A. F. (2019). The effect of protein and essential amino acid supplementation on muscle strenght and performance in patients with chronic heart failure: a systematic review. Eur. J. of Nutr., 10.1007/s00394-019-02108-z.
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schutz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 485-521.
Singer, P., Reintam Blaser, A., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., . . . Montejo, J. C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical nutrition, 48-79.
Weijs, P. J., Stapel, S. N., Groot de, S. D., Driessen, R. H., Jong, E., & Girbes, A. R. (2012). Optimal protein and energy mortality in mechanically ventilated critically ill patients: a prospective cohort study. J. Parenter. Enteral Nutr., 60e8.
Ljungqvist, O., & Man, F. d. (2009). Under Nutrition: A major health problem in Europe. Nutr. Hosp., 368-70.
Guest, J., Panca, M., Baeyens, J. P., Man, F. d., Ljungqvist, O., Pichard, C., . . . Wilson, L. (2011). Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK. Clin. Nutr., 422-429.
Kaiser, M. J., Bauer, J. M., Ramsch, C., Uter, W., Guigoz, Y., Cederholm, T., . . . Maggio, M. (2010). Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J. Am. Geriatr. Soc., 1734-1738.
Hulst, J. M., Zwart, H., Hop, W. C., & Joosten, K. F. (2010). Dutch national survey to test the strongkids nutritional risk screening tool in hospitalized children. Clin. Nutr., 106-111.
Khalatbari-Soltani, S., Mestral, C. d., & Marques-Vidal, P. (2019). Sixteen years trends in reported undernutrition. Clin. Nutr., 271-278.
Bang, U. C., Semb, S., Nordgaard-Lassen, I., & Jensen, J. E. (2009). A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr. Res., 671-675.
Finch, S., Doyle, W., Lowe, C., Bates, C. J., Prentice, A., & Smithers, G. (1998). National diet and nutrition survey: people aged 65 years and over. London: Stationary Office.
Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that vitamin D supplementation could reduce the risk of influenza and COVID-19 infections and deaths. Nutrients, 10.3390/nu12040988.
Correia, M. I., Perman, M. I., Pradelli, L., Omaralsaleh, A. J., & Waitzberg, D. L. (2018). Economic burden of hospital malnutrition and the cost-benefit of supplemental parenteral nutrition in critically ill patients in Latin America. Journal of Medical Economics, 1047-1056.
Mikkelsen, K., & Apostolopoulos, V. (2018). B Vitamins and ageing. Subcell Biochem., 451-470.
Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hubner, M., Klek, S., . . . Singer, P. (2017). ESPEN guideline: clinical nutrition in surgery. Clinical Nutrition, 623-650.
Gillis, C., & Carli, F. (2015). Promoting perioperative metabolic and nutritional care. Anesthesiology, 1455-1472.
Williams, D. G., Molinger, J., & Wischmeyer, P. E. (2019). The malnourished surgery patient: a silent epidemic in perioperative outcomes? Curr. Opin. Anaesthesiol., 405-411.
Bisschoff, S. C., Austin, P., Boeykens, K., Chourdakis, M., Cuerda, C., Jonkers-Schuitema, C., . . . Pironi, L. (2020). ESPEN guideline on home enteral nutrition. Clinical Nutrition, 5-22.
Bang, U. C., Semb, S., Nordgaard-Lassen, I., & Jensen, J. E. (2009). A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr. Res., 671-675.
Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.
Ljungqvist, O., & Man, F. d. (2009). Under Nutrition: A major health problem in Europe. Nutr. Hosp., 368-70.
Guest, J., Panca, M., Baeyens, J. P., Man, F. d., Ljungqvist, O., Pichard, C., . . . Wilson, L. (2011). Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK. Clin. Nutr., 422-429.
Kaiser, M. J., Bauer, J. M., Ramsch, C., Uter, W., Guigoz, Y., Cederholm, T., . . . Maggio, M. (2010). Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J. Am. Geriatr. Soc., 1734-1738.
Hulst, J. M., Zwart, H., Hop, W. C., & Joosten, K. F. (2010). Dutch national survey to test the strongkids nutritional risk screening tool in hospitalized children. Clin. Nutr., 106-111.
Khalatbari-Soltani, S., Mestral, C. d., & Marques-Vidal, P. (2019). Sixteen years trends in reported undernutrition. Clin. Nutr., 271-278.
MNI. (2018). Medical Nutrition Dossier. Retrieved from https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/
Correia, M. I., Perman, M. I., Pradelli, L., Omaralsaleh, A. J., & Waitzberg, D. L. (2018). Economic burden of hospital malnutrition and the cost-benefit of supplemental parenteral nutrition in critically ill patients in Latin America. Journal of Medical Economics, 1047-1056.
Finch, S., Doyle, W., Lowe, C., Bates, C. J., Prentice, A., & Smithers, G. (1998). National diet and nutrition survey: people aged 65 years and over. London: Stationary Office.
Schaafsma, G. (2012). Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr., S333-S336.
Lonnie, M., Hooker, E., Brunstrom, J. M., Corfe, B. M., Green, M. A., Watson, A. W., . . Johnstone, A. M. (2018). Protein for life: Review of optimal protein inake, sustainable dietary sources and the effect on appetite in ageing adults. Nutrients, 360.
Kiesswetter, E., Sieber, C. C., & Volkert, D. (2020). Protein intake in older people. Gerontologie+Geriatrie, 10.1007/s00391-020-01723-4.
Wagner, I., & Musso, H. (1983). New Naturally occurring amino acids. Angewandte Chemie International edition in English, 816-828.
Dancojocari. (n.d.). own work. wikimedia.
Young, V. R. (1994). Adult amino acid requirements: the case for a major revision in current recommendations. J. Nutr., 1517s-1523s.
Dietzen, D. J. (2018). Amino acids, peptides, and proteins Textbook of clinical chemistry and molecular diagnostics. Elsevier.
Carbone, J. W., & Pasiakos, S. M. (2019). Dietary protein and muscle mass: translating science to application. Nutrients, 1136.
Carbone, J. W., McClung, J. P., & Pasiakos, S. M. (2019). Recent advances in the characterization of skeletal muscle and whole-body protein responses to dietary protein and exercise during negative energy balance. Adv. Nutri., 70-79.
Calvero. (n.d.). Selfmade with Chemdraw, public domain.
Shah, N. D., & Limetkai, B. N. (2017). The use of Medium-Chain Triglycerides in Gastrointestinal Disorders. Practical Gastroenterology, 20-28.
Ingle, D. L., Driedger, A., Traul, K. A., & Nakhasi, D. K. (1999). Dietary energy value of medium-chain triglycerides. Journal of Food Science, 960-963.
Smeets, R. L., Rao, R. V., Emst-de Vries van, S. E., De Pont, J. J., Miller, L. J., & Willems, P. H. (1998). Reduced cholecystokinin receptor phosphorylation and restored signalling in protein kinase C down-regulated rat pancreatic acinar cells. Pflugers Arch., 422-428.
Limetkai, B. N., & Zucker, S. D. (2008). Hyperammonemic encephalopathy caused by carnitine deficiency. J. Gen. Inter. Med., 210-213.
Symersky, T., Vu, M. K., & Frolich, M. (2002). The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin. Physiol. Funct. Imaging, 307-311.
Saunders, J., Smith, T., & Stroud, M. (2019). Malnutrition and undernutrition. Medicine, 152-158.
Selimoglu, M., Kansu, A., Aydogdu, S., Sarioglu, A., Erdogan, S., Dalgic, B., . . . Cokugras, F. (2021). Nutritional support in malnourished children with comprised gastrointestinal function: utility of peptide-based enteral therapy. Frontiers in Pediatrics, doi: 10.3389/fped.2021.610275.
Phillips, V., Short, N., Turner, C., & Rece, J. (2005). Peptide-based formulas: the neutraceuticals of enteral feeding. Retrieved from www.sci-health.org/sos/html_powerpoints/Phillips_ECPN_peptides.pdf
Ibrahim, H., Mansour, M., & Gendy el, Y. (2020). Peptide-based formula versus standard-based polymeric formula for critically ill children: is it superior for patients' tolerance? Arch. Med. Sci., 592-596.
Brinson, R., Hanumanthu, S., & Pitts, W. (1989). A reappraisal of the peptide-based enteral formulas: clinical applications. Nutr. Clin. Pract., 211-217.
Bang, U. C., Semb, S., Nordgaard-Lassen, I., & Jensen, J. E. (2009). A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr. Res., 671-675.
Tessier, A., & Chevalier, S. (2018). An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 10.3390/nu10081099.
Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that vitamin D supplementation could reduce the risk of influenza and COVID-19 infections and deaths. Nutrients, 10.3390/nu12040988.
Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.
Ljungqvist, O., & Man, F. d. (2009). Under Nutrition: A major health problem in Europe. Nutr. Hosp., 368-70.
Guest, J., Panca, M., Baeyens, J. P., Man, F. d., Ljungqvist, O., Pichard, C., . . . Wilson, L. (2011). Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK. Clin. Nutr., 422-429.
Kaiser, M. J., Bauer, J. M., Ramsch, C., Uter, W., Guigoz, Y., Cederholm, T., . . . Maggio, M. (2010). Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J. Am. Geriatr. Soc., 1734-1738.
Hulst, J. M., Zwart, H., Hop, W. C., & Joosten, K. F. (2010). Dutch national survey to test the strongkids nutritional risk screening tool in hospitalized children. Clin. Nutr., 106-111.
Khalatbari-Soltani, S., Mestral, C. d., & Marques-Vidal, P. (2019). Sixteen years trends in reported undernutrition. Clin. Nutr., 271-278.
MNI. (2018). Medical Nutrition Dossier. Retrieved from https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/
Correia, M. I., Perman, M. I., Pradelli, L., Omaralsaleh, A. J., & Waitzberg, D. L. (2018). Economic burden of hospital malnutrition and the cost-benefit of supplemental parenteral nutrition in critically ill patients in Latin America. Journal of Medical Economics, 1047-1056.
Finch, S., Doyle, W., Lowe, C., Bates, C. J., Prentice, A., & Smithers, G. (1998). National diet and nutrition survey: people aged 65 years and over. London: Stationary Office.
Schaafsma, G. (2012). Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr., S333-S336.
Lonnie, M., Hooker, E., Brunstrom, J. M., Corfe, B. M., Green, M. A., Watson, A. W., . . . Johnstone, A. M. (2018). Protein for life: Review of optimal protein inake, sustainable dietary sources and the effect on appetite in ageing adults. Nutrients, 360.
Kiesswetter, E., Sieber, C. C., & Volkert, D. (2020). Protein intake in older people. Gerontologie+Geriatrie, 10.1007/s00391-020-01723-4.
Mikkelsen, K., & Apostolopoulos, V. (2018). B Vitamins and ageing. Subcell Biochem., 451-470.
Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019). Sarcopenia. Joint Bone Spine, 309-314.
Bonnefoy, B., Gilbert, T., Bruyere, O., Paillaud, E., Raynaud-Simon, A., Guerin, O., . . . Berrut, G. (2019). Protein supplementation to prevent loss in muscle mass and strength in frail older patients: a review. Geriatr. Psychol. Neuropsychiatr. Vieil., 137-143.
Wojzischke, J., Wijngaarden van, J., Berg van den, C., Cetinyurek-yavuz, A., Diekmann, R., Luiking, Y., & Bauer, J. (2020). Nutritional status and functionality in geriatric rehabilitation patients: a systematic review and meta-analysis. Eur. Geriatr. Med., 195-207.
Tieland, M., Borgonjen-van den Berg, K. J., Loon van, L. J., & Groot de, L. C. (2012). Dietary protein intake in community-dwelling, frail, and institutionalized elderly people: scope for improvement. Eur. J. Nutr., 173-179.
Bossola, M., Pacelli, F., Rosa, F., Tortorelli, A., & Bastista, D. G. (2011). Review: does nutrition support stimulate tumor growth in humans? Nutr. Clin. Pract., 174-180.
Prado, C. M., Purcell, S. A., & Laviano, A. (2020). Nutrition interventions to treat low muscle mass in cancer. Journal of cachexia, sarcopenia and muscle, 366-380.
Arends, J., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E., Erickson, N., . . . McMillan, D. C. (2017). ESPEN expert group recommendations for action against cancer-related malnutrition. Clinical Nutrition, 1187-1196.
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., & McCargar, L. J. (2013). Cancer cachexia in the age of obesity; skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol., 1539-1547.
Bauer, J., Morley, J. E., Schols, A. M., Ferrucci, L., Cruz-Jentoft, A. J., & Dent, E. (2019). Sarcopenia: a time for action. An SCWD Position Paper. J. Cachexia Sarcopenia Muscle, 0.
Collins, P. F., Yang, I. A., Chang, Y., & Vaughan, A. (2019). Nutritional support in chronic obstructive pumonary disease (COPD): an evidence update. J. Thorac Dis., S2230-S2237.
Collins, P. F., Elia, M., & Stratton, R. J. (2013). Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology, 616-629.
Habaybeh, D., Bordinhon de Moraes, M., Slee, A., & Avgerinou, C. (2020). Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or chachexia: a systematic review and meta-analysis. Haert Failure Reviews, 10.1007/s10741-020-09937-9.
Nichols, S., McGregor, G., Al-Mohammad, A., Ali, A. N., Tew, G., & O'Doherty, A. F. (2019). The effect of protein and essential amino acid supplementation on muscle strenght and performance in patients with chronic heart failure: a systematic review. Eur. J. of Nutr., 10.1007/s00394-019-02108-z.
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schutz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 485-521.
Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hubner, M., Klek, S., . . . Singer, P. (2017). ESPEN guideline: clinical nutrition in surgery. Clinical Nutrition, 623-650.
Williams, D. G., Molinger, J., & Wischmeyer, P. E. (2019). The malnourished surgery patient: a silent epidemic in perioperative outcomes? Curr. Opin. Anaesthesiol., 405-411.
Gillis, C., & Carli, F. (2015). Promoting perioperative metabolic and nutritional care. Anesthesiology, 1455-1472.
Singer, P., Reintam Blaser, A., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., . . . Montejo, J. C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical nutrition, 48-79.
Weijs, P. J., Stapel, S. N., Groot de, S. D., Driessen, R. H., Jong, E., & Girbes, A. R. (2012). Optimal protein and energy mortality in mechanically ventilated critically ill patients: a prospective cohort study. J. Parenter. Enteral Nutr., 60e8.
Bisschoff, S. C., Austin, P., Boeykens, K., Chourdakis, M., Cuerda, C., Jonkers-Schuitema, C., . . . Pironi, L. (2020). ESPEN guideline on home enteral nutrition. Clinical Nutrition, 5-22.
Smith, T., Cawood, A., Walters, E., Guildford, N., & Stratton, R. (2020). Ready-made oral nutritional supplements improve nutritional outcome and reduce health care use - a randomised trial in older malnourished people in primary care. Nutrients, doi:10.3390/nu12020517.
Hubbard, G., Elia, M., Holdoway, A., & Stratton, R. (2012). A systematic review of compliance to oral nutritional supplements. Clin. Nutrition, 293-312.
Serguy, D., Hubert, H., Robert, J., Meunier, J., Guerin, O., & Raynaud-Simon, A. (2020). Compliance to ral nutritional supplementation decreases the risk of hospitalisation in malnourished older adults without extra health care cost: Prospective observational cohort study. Clin. Nutrition, 1900-1907.
Bang, U. C., Semb, S., Nordgaard-Lassen, I., & Jensen, J. E. (2009). A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr. Res., 671-675.
Tessier, A., & Chevalier, S. (2018). An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 10.3390/nu10081099.
Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that vitamin D supplementation could reduce the risk of influenza and COVID-19 infections and deaths. Nutrients, 10.3390/nu12040988.
Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.
Ljungqvist, O., & Man, F. d. (2009). Under Nutrition: A major health problem in Europe. Nutr. Hosp., 368-70.
Guest, J., Panca, M., Baeyens, J. P., Man, F. d., Ljungqvist, O., Pichard, C., . . . Wilson, L. (2011). Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK. Clin. Nutr., 422-429.
Kaiser, M. J., Bauer, J. M., Ramsch, C., Uter, W., Guigoz, Y., Cederholm, T., . . . Maggio, M. (2010). Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J. Am. Geriatr. Soc., 1734-1738.
Hulst, J. M., Zwart, H., Hop, W. C., & Joosten, K. F. (2010). Dutch national survey to test the strongkids nutritional risk screening tool in hospitalized children. Clin. Nutr., 106-111.
Khalatbari-Soltani, S., Mestral, C. d., & Marques-Vidal, P. (2019). Sixteen years trends in reported undernutrition. Clin. Nutr., 271-278.
MNI. (2018). Medical Nutrition Dossier. Retrieved from https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/
Correia, M. I., Perman, M. I., Pradelli, L., Omaralsaleh, A. J., & Waitzberg, D. L. (2018). Economic burden of hospital malnutrition and the cost-benefit of supplemental parenteral nutrition in critically ill patients in Latin America. Journal of Medical Economics, 1047-1056.
Finch, S., Doyle, W., Lowe, C., Bates, C. J., Prentice, A., & Smithers, G. (1998). National diet and nutrition survey: people aged 65 years and over. London: Stationary Office.
Schaafsma, G. (2012). Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr., S333-S336.
Lonnie, M., Hooker, E., Brunstrom, J. M., Corfe, B. M., Green, M. A., Watson, A. W., . . . Johnstone, A. M. (2018). Protein for life: Review of optimal protein inake, sustainable dietary sources and the effect on appetite in ageing adults. Nutrients, 360.
Kiesswetter, E., Sieber, C. C., & Volkert, D. (2020). Protein intake in older people. Gerontologie+Geriatrie, 10.1007/s00391-020-01723-4.
Mikkelsen, K., & Apostolopoulos, V. (2018). B Vitamins and ageing. Subcell Biochem., 451-470.
Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019). Sarcopenia. Joint Bone Spine, 309-314.
Bonnefoy, B., Gilbert, T., Bruyere, O., Paillaud, E., Raynaud-Simon, A., Guerin, O., . . . Berrut, G. (2019). Protein supplementation to prevent loss in muscle mass and strength in frail older patients: a review. Geriatr. Psychol. Neuropsychiatr. Vieil., 137-143.
Wojzischke, J., Wijngaarden van, J., Berg van den, C., Cetinyurek-yavuz, A., Diekmann, R., Luiking, Y., & Bauer, J. (2020). Nutritional status and functionality in geriatric rehabilitation patients: a systematic review and meta-analysis. Eur. Geriatr. Med., 195-207.
Tieland, M., Borgonjen-van den Berg, K. J., Loon van, L. J., & Groot de, L. C. (2012). Dietary protein intake in community-dwelling, frail, and institutionalized elderly people: scope for improvement. Eur. J. Nutr., 173-179.
Bossola, M., Pacelli, F., Rosa, F., Tortorelli, A., & Bastista, D. G. (2011). Review: does nutrition support stimulate tumor growth in humans? Nutr. Clin. Pract., 174-180.
Prado, C. M., Purcell, S. A., & Laviano, A. (2020). Nutrition interventions to treat low muscle mass in cancer. Journal of cachexia, sarcopenia and muscle, 366-380.
Arends, J., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E., Erickson, N., . . . McMillan, D. C. (2017). ESPEN expert group recommendations for action against cancer-related malnutrition. Clinical Nutrition, 1187-1196.
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., & McCargar, L. J. (2013). Cancer cachexia in the age of obesity; skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol., 1539-1547.
Bauer, J., Morley, J. E., Schols, A. M., Ferrucci, L., Cruz-Jentoft, A. J., & Dent, E. (2019). Sarcopenia: a time for action. An SCWD Position Paper. J. Cachexia Sarcopenia Muscle, 0.
Collins, P. F., Yang, I. A., Chang, Y., & Vaughan, A. (2019). Nutritional support in chronic obstructive pumonary disease (COPD): an evidence update. J. Thorac Dis., S2230-S2237.
Collins, P. F., Elia, M., & Stratton, R. J. (2013). Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology, 616-629.
Habaybeh, D., Bordinhon de Moraes, M., Slee, A., & Avgerinou, C. (2020). Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or chachexia: a systematic review and meta-analysis. Haert Failure Reviews, 10.1007/s10741-020-09937-9.
Nichols, S., McGregor, G., Al-Mohammad, A., Ali, A. N., Tew, G., & O'Doherty, A. F. (2019). The effect of protein and essential amino acid supplementation on muscle strenght and performance in patients with chronic heart failure: a systematic review. Eur. J. of Nutr., 10.1007/s00394-019-02108-z.
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schutz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 485-521.
Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hubner, M., Klek, S., . . . Singer, P. (2017). ESPEN guideline: clinical nutrition in surgery. Clinical Nutrition, 623-650.
Williams, D. G., Molinger, J., & Wischmeyer, P. E. (2019). The malnourished surgery patient: a silent epidemic in perioperative outcomes? Curr. Opin. Anaesthesiol., 405-411.
Gillis, C., & Carli, F. (2015). Promoting perioperative metabolic and nutritional care. Anesthesiology, 1455-1472.
Singer, P., Reintam Blaser, A., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., . . . Montejo, J. C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical nutrition, 48-79.
Weijs, P. J., Stapel, S. N., Groot de, S. D., Driessen, R. H., Jong, E., & Girbes, A. R. (2012). Optimal protein and energy mortality in mechanically ventilated critically ill patients: a prospective cohort study. J. Parenter. Enteral Nutr., 60e8.
Bisschoff, S. C., Austin, P., Boeykens, K., Chourdakis, M., Cuerda, C., Jonkers-Schuitema, C., . . Pironi, L. (2020). ESPEN guideline on home enteral nutrition. Clinical Nutrition, 5-22.
Smith, T., Cawood, A., Walters, E., Guildford, N., & Stratton, R. (2020). Ready-made oral nutritional supplements improve nutritional outcome and reduce health care use - a randomised trial in older malnourished people in primary care. Nutrients, doi:10.3390/nu12020517.
Hubbard, G., Elia, M., Holdoway, A., & Stratton, R. (2012). A systematic review of compliance to oral nutritional supplements. Clin. Nutrition, 293-312.
Serguy, D., Hubert, H., Robert, J., Meunier, J., Guerin, O., & Raynaud-Simon, A. (2020). Compliance to ral nutritional supplementation decreases the risk of hospitalisation in malnourished older adults without extra health care cost: Prospective observational cohort study. Clin. Nutrition, 1900-1907.
Taherian, M., Samadi, P., Rastegar, H., Faramarzi, M., Rostami-Nejad, M., Yazdi, M., . . . Yazdi, Z. (2019). An overview on probiotics as an alternative strategy for prevention and treatment of human diseases. Iran J. Pharm. Res., 31-50.
Ranadheera, R., Baines, S., & Adam, M. (2010). Importance of food in probiotic efficacy. Food Res. Int., 1-7.
Oelschlaeger, T. (2010). Mechanisms of probiotic actions - a review. Int. J. Med. Microbiol., 57-62.
Rondanelli, M., Faliva, M., Perna, S., Giacosa, A., Peroni, G., & Castellazi, A. (2017). Using probiotics in clinical practice: Where are we now? A review of exising meta-analyses. Gut Microbes, 521-543.
Khalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014). Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension, 897-903.
Zhang, Q., Wu, Y., & Fei, X. (2015). Effects of probiotics on body weight and body-mass indez: A systemic review and meta-analysis of randomized, controlled trials. Int. J. Food Sci. Nutr., 571-580.
Park, S., & Bae, J. (2015). Probiotics for weight loss: a systematic review and meta-analysis. Nutr. Res., 566-575.
Shimizu, M., Hashiguchi, M., Shiga, T., Tamura, H., & Mochizuki, M. (2015). Meta-analysis: Effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolemic individuals. PLoS One, doi.org/10.1371/journal.pone.0139795.
McFarland, L., Huang, Y., Wang, L., & Malfertheiner, P. (2016). Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Gastroeneterol. J., 546-561.
Naidoo, K., Gordon, M., Fagbemi, A., Thomas, A., & Akobeng, A. (2011). Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst. Rev., PMID:22161412.
Fujiya, M., Ueno, N., & Kohgo, Y. (2014). Probiotic treatments for induction and maintenance of remission in inflammatory bowel disease. A meta-analyses or randomized controlled trials. Clin. J. Gastroenterol., doi.org/10.1007/s12328-013-0440-8.
Didari, T., Mozaffari, S., Nikfar, S., & Abdollahi, M. (2015). Effectiveness of probiotics in irritable bowel syndrome. Updated systematic review with meta-analysis. World J. Gastroenterol/, doi.org/10.3748/wjg.v21.i10.3072.
Dimidi, E., Christodoulides, S., Fragkos, K., Scott, S., & Whelan, K. (2014). The effect of probiotics on functional constipation in adults: A systemic review and meta-analyses of randomized controlled trials. Am. J. Clin. Nutr., 1075-1084.
Goldenberg, J., Ma, S., Saxton, J., Martzen, M., Vandvik, P., Thorlund, K., . . . Johnston, B. (2013). Probiotics for the prevention of Closteridium difficile-associated diarrhea in adults and children. Cochrane Database Syst. Rev., PMID: 23728658.
Goldenberg, J., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. (2015). Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev, PMID: 26695080.
Hao, Q., Dong, B., & Wu, T. (2015). Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst. Rev., PMID:25927096.
Pitsillides, L., Pellino, G., Tekkis, P., & Kontovounisios, C. (2021). The effect of perioperative administration of probiotics on colorectal cancer surgery outcomes. Nutrients, doi: 10.3390/nu13051451.
Lee, N., & Paik, H. (2021). Prophylactic effects of probiotics on respiratory viruses including COVID-19: a review. Food Sci. Biotechnol., doi.org/10.1007/s10068-021-00913-z.
Tang, H., Bohannon, L., Lew, M., Jensen, D., Jung, S., Zhao, A., . . . Wischmeyer, P. (2021). Randomised, double-blind, placebo-controlled trial of probiotics to eliminate COVID-19 transmission in exposed household contacts (PROTECT-EHC): a clinical trial protocol. BMJ open, doi:101136/bmjopen-2020-047069.
Davison, J., & Wischmeyer, P. (2018). Probiotic and synbiotic therapy in the critically ill: State of the art. The end-to-end journal, doi:.org/10.1016/j.nut.2018.07017.
Besselink, M., Santvoort van , H., Buskens, E., Boermeester, M., Goor van, H., Timmerman, H., . . . Witteman, B. (2008). Probiotic prophylaxis in predicted severe acute pancreatitiis: a randomsied, double-blind, placebo-controlled trial. Lancet, 651-659.
Liao, W., Chen, C., Wen, T., & Zhao, Q. (2021). Probiotics for the prevention of antibioitic-assocated diarrhea in adults. J. Clin. Gastroenterol., 469-480.
Liu, D., Zeng, L., Yan, Z., Jia, J., Gao, J., & Wei, Y. (2020). The mechanisms and safety of probiotics against toxigenic clostridium difficile. Exp. Rev. Anti-Infec. Ther., doi.org/10.1080/14787210.2020.1778464.
Debast, S., Bauer, M., Kuijper, E., & et al. (2014). European society of clinical microbiology and infectious diseases: update of the treatment guidance document for Clostridium difficile infection. . Clin. Microbiol. Infect., 1-26.
Williams, E., Stimpson, J., Wang, D., Plummer, S., Garaiova, I., Barker, E., & Corfe, B. (2008). Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment. Pharm. & Ther., 97-103.
Plummer, S., Garaiova, I., Sarvotham, T., Cottrell, S., Scouiller le S., Weaver, M., . . . Hunter, J. (2005). Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int. J. Antimicrob. Agents, 69-74.
Madden, J., Plummer, S., Tang, J., Garaiova, I., Plummer, N., Herbison, M., . . . Shirakawa, T. (2005). Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double blind, placebo-controlled pilot study. Int. Immunopharm., 1091-1097.
Plummer, S., Weaver, M., Harris, J., Dee, P., & Hunter, J. (2004). Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int. Microbiol., 59-62.
WHO. (2018). Cancer. Retrieved from https://www.who.int/en/news-room/fact-sheets/detail/cancer
Rauh, S., Antonuzzo, A., Bossi, P., Eckert, R., Fallon, M., Frobe, A., . . . Villarini, A. (2018). Nutritionin patients with cancer: a new are for medical oncologists? A practising oncologist's interdisciplinary position paper. ESMO open, Doi:10.1136/esmoopen-2018-000345.
Pressoir, M., Desne, S., Berchery, D., Rossignol, G., Poirree, B., & Meslier, M. (2010). Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive cancer Centres. Br. J. Cancer, 966-971.
Wie, G. A., Cho, Y. A., Kim, S. Y., Kim, S. M., Bae, J. M., & Joung, H. (2010). Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the national cancer center in Korea. Nutrition, 263-268.
Hebuterne, X., Lemarie, E., Michallet, M., Montreuil de, C. B., Schneider, S. M., & Goldwasser, F. (2014). Prevalence of malnutrition and current use in nutrition support in patients with cancer. J. Parenter. Enteral Nutr., 196-204.
Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E., . . . Lisanti, M. P. (2017). ESPEN expert group recommendations for action against cancer-related malnutrition. Clinical Nutrition, 1187-1196.
Freijer, K., Tan, S. S., Koopmanschap, M. A., Meijers, J. M., Halfens, R. J., & Nuijten, M. J. (2013). The economic costs of disease related malnutrition. Clinical Nutrition, 136-141.
Barr, R. D., & Ladas, E. J. (2020). The role of nutrition in pediatric oncology. Expert Review of Anticancer Therapy, 10.1080/14737140.2020.1719834.
Laird, B. J., Fallon, M., Hjermstad, M. J., Tuck, S., Kaasa, S., & Klepstad, P. (2016). Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response. J. Clin. Oncol., 2769-2775.
Fearon, K., Arends, J., & Baracos, V. (2013). Understanding the mechanisms and treatment options in cancer cachexia. Nat. Rev. Clin. Oncol., 90-99.
Argiles, J. M., Busquets, S., Stemmler, B., & Lopez-Soriano, F. J. (2014). Cancer cachexia: understanding the molecular basis. Nat. Rev. Cancer, 754-762.
Walsh, J. C., Lebedev, A., Aten, E., Madsen, K., Marciano, L., & Kolb, H. C. (2014). The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities. Antioxid. Redox Signal., 1516-1554.
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., & Bozzetti, F. (2017). ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition, 11-48.
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., & Fainsinger, R. L. (2011). Definition and classification of cancer cachexia: an international consensus. Lancet Oncol., 489-495.
Stanga, Z., Brunner, A., Leuenberger, M., Grimble, R. F., Shenkin, A., & Allison, A. P. (2008). Nutrition in clinical practice- the refeeding syndrome: illustrative cases and guidelines for prevention and treatment. Eur. J. Clin. Nutr., 687-694.
Lee, J. L., Leong, L. P., & Sim, S. L. (2016). Nutrition intervention approaches to reduce malnutrition in oncology patients: a systematic review. Support Care Cancer, 469-480.
Prado, C. M., Mourtzakis, M., Baracos, V., Reiman, T., Sawyer, M., & McCargar, L. J. (2010). Overweight and obese patients with solid tumors may have sarcopenia, poor prognosis and early features of cachexia. Int. J. Body Compos. Res., 7-15.
Prado, C. M., Purcell, S. A., & Laviano, A. (2020). Nutrition interventions to treat low muscle mass in cancer. Journal of Cachexia, Sarcopenia and Muscle, 366-380.
Ravasco, P. (2019). Nutrition in Cancer Patients. Journal of Clinical Medicine, 10.3390/jcm8081211.
Grober, U., Holzhauer, P., Kisters, K., Holick, M. F., & Adamietz, I. A. (2016). Micronutrients in oncology intervention. Nutrients, 10.3390/nu8030163.
Jatoi, A., Williams, B. A., Marks, R., Nichols, F. C., Aubry, M., Wampfler, J., & Yang, P. (2005). Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the mayo clinic lung cancer cohort. Nutr. Cancer, 77-84.
Bang, U. C., Semb, S., Nordgaard-Lassen, I., & Jensen, J. E. (2009). A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr. Res., 671-675.
Tessier, A., & Chevalier, S. (2018). An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 10.3390/nu10081099.
Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that vitamin D supplementation could reduce the risk of influenza and COVID-19 infections and deaths. Nutrients, 10.3390/nu12040988.
Cashman, K., Dowling, K., Skrabakova, Z., Gonzales-Gross, M., Valtuena, J., & Henauw de, S. (2016). Vitamin D deficiency in Europe: pandemic? Am. J. Clin. Nutr., 1033-1044.
Martucci, G., Tuzzolino, F., Arcadipane, A., Pieber, T., Schnedl, C., & Purkart, T. (2017). The effect of high-dose cholecalciferol on bioavailable vitamin D levels in critically ill patients: a post hoc analysis of the VITdAL-ICU trial. Intensiv. Care Med., 1732-1734.
Haq, A., Svobodova, J., Imran, S., Stanford, C., & Razzaque, M. (2016). Vitamin D deficiency: a single centre analysis of patients from 136 countries. J. Steroid Biochem. Mol. Biol., 209-213.
Lu, Z., Chen, T., Zhang, A., Persons, K., Kohn, N., Berkowitz, R., Holick, M. (2007). An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J. Steroid Biochem. Mol. Biol., 642-644.
GOV.UK. (2020, November 28). Retrieved from Preparing for winter: vitamin D: https://www.gov.uk/government/publications/vitamin-d-supplementation-during-winter-phe-and-nice-statement/statement-from-phe-and-nice-on-vitamin-d-supplementation-during-winter
National Institutes of Health. (2021, January 29). Retrieved from Vitamin D: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Amrein, K., Scherkl, M., Hoffmann, M., Neuwersch-Sommeregger, S., Kostenberger, M., Tmava Berisha, A., . . . Malle, O. (2020). Vitamin D deficiency 2.0: an update on the current status worldwide. Eur. J. Clin. Nutr., doi.org/10.1038/s41430-020-0558-y.
Holick, M., Binkley, N., Bischoff-Ferrari, H., Gordon, C., Hanley, D., & Heany, R. (2011). Evaulation, treatment and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab., 1911-1930.
Vieth, R. (2004). Vitamin D is not a hormone, and not a synonym for 1,25-dihydroxy-vitamin D, its analogs of deltanoids. J. Steroid Biochem. Mol. Biol., 89-90.
Vieth, R. (2020). Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol. . Eur. J. Clin. Nutr., doi.org/10.1038/s41430-020-0697-1.
Vieth, R. (2007). Vitamin D toxicity, policy, and science. J. Bone Miner. Res, V64-V68.
EFSA Panel on dietitic products, E. (2012). Scientific opinion on the tolerable upper intake levels of vitamin D. EFSA J., 2813.
Hathcock, J., Shao, A., Vieth, R., & Heaney, R. (2007). Risk assessment for vitamin D. Am. J. Clin. Nutr., 6-18.
Martineau, A., Jollife, D., Hooper, R., Greenberg, L., Aloia, J., & Bergman, P. (2017). Vitamin D supplementation to prevent acute respiratory tract infections; systematic review and meta-analysis of individual participant data. B. M. J., i6583.
Bjelakovic, G., Gluud, L., Nikolova, D., Whitfield, K., Wetterslev, J., & Simonetti, R. (2014). Vitamin D supplementation for prevention of mortality in adults. Cochrane Datab. Syst. Rev., doi.org/10.1002/14651858.CD007470.pub3.
Gaksch, M., Jorde, R., Grimnes, G., Joakimsen, R., Schirmer, H., & Wilsgaard, T. (217). Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a Eurpoean consortium. PLOS ONE, e0170791.
Vos, R., Ruttens, D., Verleden, S., Vandermeulen, E., Bellon, H., & Van Herck, A. (2017). High-dose vitamin D after lung transplantation: a randomized trial. J. Heart Lung Transplant, 897-905.
Ma, H., Zhou, T., Heianza, Y., & Qi, L. (2021). Habitual use fo vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infcetion: a prospective study in UK biobank. Am. J. Clin. Nutr., doi:101093/ajcn/nqaa381.
Demir, M., Demir, F., & Aygun, H. (2021). Vitamin D deficiency is associated with COVID-19 positivity and the severity of the diseases. J. Med. Virol., doi: 10.1002/jm.26832.
Rostami, M., Tehrani, F., Simbar, M., Bidhendi Yarandi, R., Minooe, S., & Hollis, B. (2018). Effectiveness of prenatal vitamin D deficiency screening and treatment program: a stratified randomized field trial. J. Clin. Endocrinol. Metab., 2936-2948.
Kusunose, K., Okushi, Y., Okayama, Y., Zheng, R., Abe, M., Nakai, M., . . . Tobiume, T. (2021). Association between vitamin D and heart failure mortality in 10,974 hospitalized individuals. Nutrients, doi:10.3390/nu13020335.
Vitetta, L. et al. Personal communications June 2021
Tessier, A., & Chevalier, S. (2018). An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 10.3390/nu10081099.
National Institutes of Health. (2021, January 29). Retrieved from Vitamin D: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Cunnane, S. (2003). Problems with essential fatty acids: time for a new paradigm? Progress in Lipid Research, 544-568.
Troesch, B., Eggersdorfer, M., Laviano, A., Rolland, Y., David Smith, A., Warnke, I., . . . Calder, P. (2020). Expert opinion on benefits of long-chain omega-3 fatty acids (DHA and EPA) in aging and clinical nutrition. Nutrients, doi:10.3390/nu12092555.
European Food Safety Authority. (2010). Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids and cholesterol. EFSA J., 1461.
Food and agricultural organization. (2010). Fats and fatty acids in human nutrition - report of an expert consultation. FAO Food and Nutrition Paper; Food and agricultural organization Rome Italy.
Chinese Nutrition Society. (2013). Chinese Dietary Reference Intakes Summary . People's Medical Publishing House; Beijing, China, 16.
Institute of Medicine Dietary Reference Intakes. (2006). The essential guide to nutrient requirements. The national academies press, Washington DC, USA, 1344.
Stark, K., Elswyk van, M., Higgins, M., Weatherford, C., & Salem, N. (2016). Global survey of the omega-3 fatty acids, docosahexanoic acid and eicosapentaenoic acid in the bloodstream of healthy adults. Prog. Lipid Res., 132-152.
Carvalho de, C., & Caramujo, M. (2018). The various roles of fatty acids. Molecules, 2583.
Chiang, N., & Serhan, C. (2020). The specialised pro-resolving mediator network: an update on in vivo production and actions. Essay Biochem., 443-462.
Landi, F., Calvani, R., Tosato, M., Martone, A., Ortolani, E., Savera, G., . . . Marzetti, E. (2016). Anorexia of aging: risk factors, consequences and potential treatments. Nutrients, 69.
Cederholm, T., Barazzoni, R., Austin, P., Ballmer, P., Biolo, G., Bischoff, S., . . . Holst, M. (2017). ESPEN guidelines on definitions and terminology of clinical nutrition. Clin. Nutr., 49-64.
Clegg, A., Young, J., Iliffe, S., Rikkert, M., & Rockwood, K. (2013). Frailty in elderly people. Lancet, 752-762.
Cruz-Jentoft, A., Baeyens, J., Bauer, J., Boirie, Y., Cederholm, T., Landi, F., . . . Schneider, S. (2010). European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis. Age Ageing, 412-423.
Hutchins-Wiese, H., Kleppinger, A., Annis, K., Liva, E., Lammi-Keefe, C., Durham, H., & Kenny, A. (2013). The impact of supplemental n-3 long chain polyunsaturated fatty acids and dietary antioxidant on physical performance in postmenopausal women. J. Nutr. Health Aging, 76-80.
Smith, G., Julliand, S., Reeds, D., Sinacore, D., Klein, S., & Mittendorfer, B. (2015). Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am. J. Clin. Nutr., 115-122.
Mondello, P., Mian, M., Aloisi, C., Fama, F., Mondello, S., & Pitini, V. (2015). Cancer cachexia syndrome: pathogenesis, diagnosis and new therapeutic options. Nutr Cancer, 12-26.
Diako, C., Charles, K., McMillan, D., & Clarke, S. (2014). Cancer-related inflammation and treatment effectiveness. Lancet Oncol., e493-e503.
Morland, S., Martins, K., & Mazurak, V. (2016). n-3 poluunsaturated fatty acid supplementation during cancer chemotherapy. J. Nutr. Intermed. Metab., 107-116.
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., . . . Kaas, S. (2017). ESPEN guidelines on nutrition in cancer patients. Clin. Nutr., 11-48.
Blarigan van, E., Fuchs, C., Niedzwiecki, D., Ye, X., Zhang, S., Song, M., . . . Mowat, R. (2018). Marine omega-3 polyunsaturated fatty acid and fish intake after colon cancer diagnosis and survival. Cancer Epidemiol. Biomark. Prev., 438-445.
Chousterman, B., Swirski, F., & Weber, G. (2017). Cytokine storm and sepsis disease pathogenesis. Semin. Immunopathol., 517-528.
Pontes-Arruda, A., Demichele, S., Seth, A., & Singer, P. (2008). The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome; a meta-analysis of outcome data. J. Parenter. Enter. Nutr., 596-605.
McClave, S., Taylor, B., Martindale , R., Warren, M., Johnson, D., Braunschweig, C., . . . Rice, T. (2016). Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine and american society for parenteral and enteral nutrition. J. Parenter. Enter. Nutr., 159-211.
Critical care nutrition. Canadian clinical practice guidelines: composition of enteral nutrition: Fish Oils, borage oils and antioxidants. (2015). Retrieved from https://www.criticalcarenutrition.com/docs/cpgs%202015/summary%20cpgs%202015%20vs%202013.pdf
Fu, Y., Wang, Y., Gao, H., Li, D., Jiang, R., Ge, L., . . . Xu, K. (2021). Associations among dietary omega-3 polyunsaturated fatty acids, the gut microbiota and intestinal immunity. Mediators Inflamm., doi: 10.1155/2021/8879227.
Arnardottir, H., Pawelzik, S., Wistbacka, U., Artiach, G., Hofman, R., Reinholdsson, I., . . . Religa, D. (2021). Stimulating the resolution of inflammation through omega-3 polyunsaturated fatty acids in COVID-19: Rationale for the COVID-omega-Ftrial. Front. Physiol., doi.org/10.3389/fphys.2020.624657.